Collectively, these findings demonstrate that under glucose restriction, LYN-1604-activated ULK1 effectively promotes mitophagy, preserves OXPHOS functionality, and consequently drives malignant progression of CRC cells. This evidence concerns the gene ULK1 and colorectal carcinoma.